Live Breaking News & Updates on China Health Industry Co

Stay updated with breaking news from China health industry co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

REPLICEL LIFE SCIENCES : CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K -November 30, 2023 at 01:09 pm EST

REPLICEL LIFE SCIENCES INC.

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the six months ended September 30, 2023 and 2022

. ....

United States , British Columbia , Hong Kong , Lee Buckler , David Hall , Replicel Life Sciences Inc , Company Stock Option Plan , Company Or Replicel , International Financial Reporting Standards , Shiseido Company , Company Options , Venture Exchange , Party Transactions , Bus Partnership , Trichoscience Innovations Inc , International Accounting Standards Board , Mainpointe Pharmaceuticals , Technology Transfer Agreement , China Health Industry Co , While The Company , National Instrument , Given The Company , Canadian Dollars , Interim Financial , Consolidated Interim Statements , Cel Life Sciences ,

REPLICEL LIFE SCIENCES : CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K -October 24, 2023 at 11:14 am EDT

REPLICEL LIFE SCIENCES INC.

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the six months ended June 30, 2023 and 2022

. ....

British Columbia , Hong Kong , United States , Lee Buckler , David Hall , Party Transactions , Bus Partnership , Venture Exchange , Trichoscience Innovations Inc , International Financial Reporting Standards , Company Options , Shiseido Company , China Health Industry Co , Replicel Life Sciences Inc , Mainpointe Pharmaceuticals , International Accounting Standards Board , Company Stock Option Plan , Technology Transfer Agreement , While The Company , Company Or Replicel , National Instrument , Given The Company , Canadian Dollars , Interim Financial , Consolidated Interim Statements , Cel Life Sciences ,

RepliCel Life Sciences : CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS - Form 6-K

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

For the three months ended March 31, 2023 and 2022

Notice of No Auditor. | May 31, 2023 ....

United States , Hong Kong , British Columbia , Lee Buckler , David Hall , While The Company , Mainpointe Pharmaceuticals , Technology Transfer Agreement , Given The Company , Company Stock Option Plan , Company Or Replicel , International Accounting Standards Board , Share Of The Company , Replicel Life Sciences Inc , Venture Exchange The , Venture Exchange , Party Transactions , Shiseido Company , Bus Partnership , International Financial Reporting Standards , Company Options , China Health Industry Co , National Instrument , Trichoscience Innovations Inc , Canadian Dollars , Interim Financial ,